Aspiritech is excited to introduce a new monthly feature that highlights one of our amazing Board Members. Each month, we will share these essential leadership collaborators’ unique stories, insights, and contributions to our organization and the neurodiversity movement.
This month, we’re proud to feature Brad Zelinger, whose dedication and expertise have been invaluable to Aspiritech’s mission and growth.
Meet Brad Zelinger
Brad is the Founder and CEO of Stride Autism Centers, a multi-state, center-based provider of evidence-based therapy for preschool children with autism. Inspired by his adult sister who has a severe ASD-related disorder called Rett Syndrome, Brad is personally and professionally dedicated to supporting individuals with complex needs.
Brad began his career in investment banking at Moelis & Company in New York. Before founding Stride, Brad was a private equity investor at Madison Dearborn Partners and TZP Group, where he evaluated, executed and oversaw investments in growth-oriented companies.
Brad earned an MBA from Harvard Business School and a BBA with High Distinction from the University of Michigan Ross School of Business. Brad serves on the Boards of Rett Syndrome Research Trust (RSRT) and Aspiritech and was Treasurer of the Illinois Association for Behavior Analysis (ILABA).
How Brad Relates to Aspiritech’s Mission
Brad shares, “I am motivated to promote Aspiritech’s growth because they are uniquely capable of enabling rewarding career opportunities for neurodiverse adults. Additionally, as the brother of an individual with an autism-related disorder, their mission is very close to home for me.”
Support Aspiritech
Aspiritech is a world-class QA testing company that empowers individuals on the autism spectrum to fulfill their potential through meaningful employment combined with social opportunity. We’re working together for a world that embraces neurodiversity by valuing talents, supporting challenges, and welcoming differences.
If our mission and vision resonate with you, consider supporting our cause by becoming a monthly donor today.
